Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) established initial surge of 4.49% at $7.92, as the Stock market unbolted on Wednesday, before settling in for the price of $7.58 at the close. Taking a more long-term approach, BCRX posted a 52-week range of $6.00-$11.31.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 14.52%. Meanwhile, its Annual Earning per share during the time was 14.52%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 129.07%. This publicly-traded company’s shares outstanding now amounts to $210.52 million, simultaneously with a float of $193.68 million. The organization now has a market capitalization sitting at $1.67 billion. At the time of writing, stock’s 50-day Moving Average stood at $7.33, while the 200-day Moving Average is $8.25.
Biocryst Pharmaceuticals Inc (BCRX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Biocryst Pharmaceuticals Inc industry. Biocryst Pharmaceuticals Inc’s current insider ownership accounts for 8.10%, in contrast to 95.31% institutional ownership. According to the most recent insider trade that took place on Dec 22 ’25, this organization’s Chief Legal Officer sold 21,773 shares at the rate of 7.65, making the entire transaction reach 166,563 in total value, affecting insider ownership by 398,751.
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) Trading Performance Indicators
Let’s observe the current performance indicators for Biocryst Pharmaceuticals Inc (BCRX). It’s Quick Ratio in the last reported quarter now stands at 1.84. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.78. Similarly, its price to free cash flow for trailing twelve months is now 35.03.
In the same vein, BCRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.05, a figure that is expected to reach 0.04 in the next quarter, and analysts are predicting that it will be 0.27 at the market close of one year from today.
Technical Analysis of Biocryst Pharmaceuticals Inc (BCRX)
Now, what If we examine the latest scores posted by [Biocryst Pharmaceuticals Inc, BCRX]. During the last 5-days, its volume was lower the volume of 4.03 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 55.55% While, its Average True Range was 63.26.
Raw Stochastic average of Biocryst Pharmaceuticals Inc (BCRX) in the period of the previous 100 days is set at 71.78%, which indicates a major fall in contrast to 86.17% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.30 that was higher than 0.27 volatility it exhibited in the past 100-days period.
